This module will review the evidence for diabetes remission, as well as guideline recommendations for initiating therapy in patients with type 2 diabetes. It will also discuss the important role of the clinicians in engaging their patients in treatment decisions and individualizing treatment according to patient values, preferences, and priorities.
This program has received an educational grant or in-kind support from Novo Nordisk.